ANGELA DAMORE: Open Payments
NPI 1841522505 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 23 payments from 9 companies in 2025. Trend: 2023 $434 · 2024 $594 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $79 |
| Exact Sciences Corporation | 3 | $64 |
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Lilly USA, LLC | 3 | $53 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $29 |
| Abbott Laboratories | 1 | $20 |
Products named: ELIQUIS, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, Ozempic, Kerendia, QULIPTA, Wegovy.
Industry payments across PA — which companies pay providers there.
